Back to All Studies

About 20% of cats with hypertrophic cardiomyopathy (HCM), the most common heart disease in cats, develop clinical signs associated with the disease. Of these complications, the most devastating is cardiogenic arterial thromboembolism (clot formation), otherwise known as, saddle thrombus, one of the most distressing emergencies for cat owners. Cats with saddle thrombus develop a sudden onset of weakness and inability to use their rear legs. Researchers will look for the underlying reason why clots form in HCM cats by creating a model that mirrors the blood environment seen in these patients. By learning how blood cells, including platelets and neutrophils, interact to generate clots, researchers hope to identify proteins responsible for these interactions.This new information will help inform the development of potential therapies for this devastating disease in cats.

Study ID
D21FE-303
Study Status
Active
Start Date
12/01/2020
Grant amount awarded
$99,043
Grant recipient
University of California, Davis
Study country
United States
Investigator
Ronald Li, DVM, MVetMed, PhD, DACVECC
Study category
Hematology (Blood)